Description
The Canadian market now includes a much larger number of drugs that reflect a wider range of risks. Our drug regulatory system needs to be more agile to give people better access to the drugs they need.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Regulatory innovation for health products: Agile licensing for drugs | HTML | Open resource | |
| Regulatory innovation for health products: Agile licensing for drugs | HTML | Open resource |